Search Results

Asparaginase for Cancer: From commensal bacteria.

• Authors : Mullai, V. R.; Udham, Atig; Jadav, Ravindra

Subjects: *ASPARAGINASE; *MULTIPLE myeloma; *ASPARAGINE

• Source: Current Science (00113891). 9/25/2024, Vol. 127 Issue 6, p652-653. 2p.

Record details

Dr Reddy's subsidiary gets positive outcome for CAR-T cell trial.

Subjects: CYTOKINE release syndrome; MULTIPLE myeloma; CANCER cells

• Source: IIFL Securities. 10/9/2024, pN.PAG-N.PAG. 1p.

Record details

Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma.

• Authors : Miller, Kevin; Hashmi, Hamza; Rajeeve, Sridevi

Subjects: CHIMERIC antigen receptors; MULTIPLE myeloma; G protein coupled receptorsUNITED States. Food & Drug Administration

• Source: Frontiers in Oncology; 2024, p1-13, 13p

Record details

Multiple mechanisms contribute to acquired TRAIL resistance in multiple myeloma.

• Authors : Ticona-Pérez, Fany V.; Chen, Xi; Pandiella, Atanasio

Subjects: PEPTIDES; DEATH receptors; CELL death

• Source: Cancer Cell International; 8/5/2024, Vol. 24 Issue 1, p1-15, 15p

Record details

Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives.

• Authors : Parrondo, Ricardo D.; Ailawadhi, Sikander; Cerchione, Claudio

Subjects: BISPECIFIC antibodies; PLASMA cells; MULTIPLE myeloma

• Source: Frontiers in Oncology; 2024, p1-21, 21p

Record details

Spliced X-Box binding protein 1 predicts satisfying responsiveness and survival benefit toward bortezomib-based therapy in multiple myeloma patients.

• Authors : Zhang, Lingli¹ (AUTHOR) ; Gong, Jichang¹ (AUTHOR); Yaqiong, Li¹ (AUTHOR)

Subjects: *MULTIPLE myeloma; *CARRIER proteins; *BONE marrow cells

• Source: Hematology. Dec2022, Vol. 27 Issue 1, p1102-1109. 8p.

Record details

Progression of monoclonal gammopathy of undetermined significance to multiple myeloma is associated with enhanced translational quality control and overall loss of surface antigens.

• Authors : Ravn Berg, Sigrid; Dikic, Aida; Sharma, Animesh

Subjects: CELL surface antigens; MULTIPLE myeloma; QUALITY control

• Source: Journal of Translational Medicine; 6/7/2024, Vol. 22 Issue 1, p1-24, 24p

Record details

Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells.

• Authors : D'Agostino, Mattia; Rota-Scalabrini, Delia; Belotti, Angelo

Subjects: MULTIPLE myeloma; CANCER cells; PLASMA cells

• Source: Blood Cancer Journal; 6/7/2024, Vol. 14 Issue 1, p1-9, 9p

Record details

Interleukin‐33 increases the sensitivity of multiple myeloma cells to the proteasome inhibitor bortezomib through reactive oxygen species‐mediated inhibition of nuclear factor kappa‐B signal and stemness properties.

• Authors : Shao, Ruonan; Liu, Shuang; Liu, Wenjian

Subjects: BORTEZOMIB; REACTIVE oxygen species; PROTEASOME inhibitors

• Source: MedComm; May2024, Vol. 5 Issue 5, p1-15, 15p

Record details

Myelomatous pleural effusion in multiple myeloma-A rare presentation.

• Authors : Pradeep, Ingale Yaminy; R., Kulkarni Mayuri; S., Patil Sourabh

Subjects: PLEURAL effusions; PLASMA cells; MULTIPLE myeloma

• Source: Journal of Cancer Research & Therapeutics; Jan-Mar2024, Vol. 20, p476-478, 3p

Record details